Loading
Total declarations
Companies
▲ Purchases (12 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Jul 2022 for Entasis Therapeutics Holdings Inc., €25.2M.
Filing timeline
BuySaleInnoviva, Inc.
Insider track record
Disclosed buys
12
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-9.8%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Innoviva, Inc.: trading record in brief
Innoviva, Inc. discloses dealings in 2 companies, chiefly Armata Pharmaceuticals, Inc. and Entasis Therapeutics Holdings Inc. In total, 12 filings cover trades dated from 27 March 2020 to 11 July 2022.
On the market, this insider has only ever bought: 12 purchases, €177.3M in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2022 to date brings 4 purchases and no sales.
The median purchase comes to €13.8M. None of the 12 purchases we analysed coincided with buying by another insider of the same company within 30 days.
On 13 July 2022 came the latest disclosure, an open-market purchase for €16.6M in Entasis Therapeutics Holdings Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Innoviva, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
11,671,662 shares@ US$2.2043.4% of flowCommon StockSEC:0001140361-22-025957:0
Canonical exit: 6 Oct 2022 (T+90)
5,385,208 shares@ US$5.008.23% mcap38.7% of flowCommon StockSEC:0001567619-22-007861:0
Canonical exit: 29 Jun 2022 (T+90)
3,614,792 shares@ US$5.0036.3% of flowCommon StockSEC:0001567619-22-003750:0
Canonical exit: 10 May 2022 (T+90)
1,212,122 shares@ US$3.307.9% of flowCommon StockSEC:0001567619-21-019063:0
Canonical exit: 27 Jan 2022 (T+90)
6,268,975 shares@ US$2.0024.7% of flowCommon StockSEC:0001567619-21-012030:0
Canonical exit: 9 Sept 2021 (T+90)
3,731,025 shares@ US$2.0014.8% of flowCommon StockSEC:0001567619-21-010772:0
Canonical exit: 1 Aug 2021 (T+90)
6 of 6 declarations
